Research Topics
| Robert E LambSummaryAffiliation: AstraZeneca R and D Publications
|
Detail Information
Publications
Controlling hypertension to reduce the risk of strokeRobert E Lamb
Phaarm D, AstraZeneca LP, Wayne, PA 19087, USA
Prog Cardiovasc Nurs 17:186-91. 2002..This review briefly summarizes the significance of controlling hypertension to reduce the risk of stroke by reviewing some of the clinical trials that support pharmacologic intervention...
Aldosterone receptor antagonists: focus on eplerenoneRobert E Lamb
AstraZeneca LP, 725 Chesterbrook Boulevard, Wayne, PA 19087, USA
Prog Cardiovasc Nurs 18:54-9. 2003..The objective of this review is to summarize the renin-angiotensin-aldosterone system, emphasizing the role for aldosterone antagonism in the management of hypertension, with a focus on eplerenone...
Left ventricular diastolic dysfunction: risks, identification, and treatmentRobert E Lamb
Medical Affairs, AstraZeneca LP, 1800 Concord Pike, Wilmington, DE 19850, USA
Prog Cardiovasc Nurs 19:31-6. 2004....
Cardiovascular implications of thiazolidinedione therapyRobert E Lamb
AstraZeneca LP, Wilmington, DE 19850, USA
Prog Cardiovasc Nurs 19:116-22. 2004....
